Product logins

Find logins to all Clarivate products below.


: Cortellis

Here you will find relevant articles and insight into all Clarivate related products and news.

Understanding a rare disease through the lens of real world and prevalence data Understanding a rare disease through the lens of real world and prevalence data
Blog February 28, 2023
Understanding a rare disease through the lens of real world and prevalence data
Cortellis Epidemiology Pharma
Understanding local CMC requirements in low-resource countries Understanding local CMC requirements in low-resource countries
Blog December 11, 2020
Understanding local CMC requirements in low-resource countries
Cortellis
Blog August 31, 2020
Identifying and evaluating new products to rise above the competition
Cortellis
Blog August 23, 2020
Making data driven decisions with reliable intelligence
Cortellis
Blog August 12, 2020
Securing the best price for an out-licensed asset
Cortellis
Confidently complying with global regulatory guidelines Confidently complying with global regulatory guidelines
Blog August 10, 2020
Confidently complying with global regulatory guidelines
Cortellis
Blog August 1, 2020
Understanding when a drug can become generic
Cortellis
Blog July 16, 2020
Conducting pathway analyses to accelerate discovery research
Cortellis

Cortellis

Understanding local CMC requirements in low-resource countries Understanding local CMC requirements in low-resource countries
Blog December 11, 2020
Understanding local CMC requirements in low-resource countries
Blog August 31, 2020
Identifying and evaluating new products to rise above the competition
Blog August 23, 2020
Making data driven decisions with reliable intelligence
Blog August 12, 2020
Securing the best price for an out-licensed asset
Confidently complying with global regulatory guidelines Confidently complying with global regulatory guidelines
Blog August 10, 2020
Confidently complying with global regulatory guidelines
Blog August 1, 2020
Understanding when a drug can become generic
Blog July 16, 2020
Conducting pathway analyses to accelerate discovery research
Blog June 16, 2020
Drug repurposing for rare disease treatment leads to reduced risk
Blog March 25, 2020
Do EMA and FDA review outcomes for new active substances (NASs) align?
Blog March 11, 2020
How can we improve and accelerate patients’ access to medicines in low and middle-income countries?